GO:0098690 glycinergic synapse: Components & Methods

GO:0098690, glycinergic synapse, is a cellular component term describing a synapse that uses glycine as its neurotransmitter. Glycinergic synapses are a major class of fast inhibitory synapses in the vertebrate nervous system, and they are especially enriched in the spinal cord, brainstem, retina and some auditory nuclei [1,2]. Their inhibitory action depends on glycine release from presynaptic terminals and activation of postsynaptic glycine receptors, which are ligand-gated chloride channels [1,4]. Because chloride flux through these receptors normally hyperpolarizes or shunts the postsynaptic membrane, glycinergic synapses are central to motor coordination, sensory processing and pain gating [1,2,3]. For researchers, GO:0098690 provides a precise ontology anchor for annotating genes, proteins and cellular structures involved in glycinergic transmission [1,7]. The term is used in functional enrichment, single-cell transcriptomics and spatial proteomics to identify components of inhibitory circuits, and it helps distinguish glycinergic synapses from GABAergic or glutamatergic synapses [1,7]. Experimental work in zebrafish, rodents and cultured neurons has shown that glycinergic synapse formation and function require coordinated presynaptic release machinery, postsynaptic receptor clustering and chloride homeostasis [2,5,8]. Interest in glycinergic synapses has grown because their dysfunction is linked to human disease, including hyperekplexia, chronic pain and neuropsychiatric disorders [3,4,6]. Recent studies show that microglial pruning of glycinergic synapses can disinhibit spinal pain circuits, directly connecting this GO term to pathological pain states. At the same time, biophysical work continues to refine how receptor number, release-site geometry and transporter activity shape the kinetics of glycinergic currents. Together, these findings make GO:0098690 a high-value term for both basic neuroscience and translational research.

GO:0098690 (glycinergic synapse) is a cellular component defined by QuickGO as a synapse that uses glycine as a neurotransmitter. In practical terms, it is a specialized cell-cell junction where a presynaptic neuron releases glycine onto a postsynaptic neuron or target cell, and where postsynaptic glycine receptors convert that chemical signal into a chloride conductance [1,4]. The term covers the presynaptic release site, the synaptic cleft, and the postsynaptic receptor-scaffold complex, including glycine receptors and associated proteins such as gephyrin [1,7].

GO:0098690 is important because glycinergic synapses provide a large fraction of fast inhibitory control in the spinal cord, brainstem and retina, and their dysfunction directly alters motor, sensory and pain circuits [1,2,3]. The term enables precise annotation of genes and proteins that build these synapses, supports enrichment analysis in transcriptomic and proteomic studies, and provides a mechanistic framework for understanding inhibitory synapse pathology in hyperekplexia, chronic pain and neuropsychiatric disease [3,4,6].

The following genes and proteins are central to the structure, function and regulation of GO:0098690 (glycinergic synapse), based on published literature.

Glycinergic synapse function is regulated at multiple levels. Presynaptic glycine availability depends on GLYT2 (SLC6A5) and vesicular loading, while postsynaptic strength depends on glycine receptor number, subunit composition and gephyrin clustering [5,7]. Chloride homeostasis, maintained by KCC2 (SLC12A5), sets the polarity and efficacy of glycinergic inhibition, and KCC2 knockdown impairs glycinergic synapse maturation. Trans-synaptic adhesion through neuroligin-neurexin complexes regulates the balance between inhibitory and excitatory synapses. In pathological states, microglial pruning of glycinergic synapses can remove inhibitory input and disinhibit spinal pain circuits.

Disruption of glycinergic transmission causes hyperekplexia, a neurological disorder characterized by exaggerated startle responses and stiffness. The disease is linked to dysfunction of glycine receptors and associated proteins, highlighting the clinical importance of GO:0098690. Studies of glycinergic transmission provide a mechanistic basis for understanding these disorders.

Microglial pruning of glycinergic synapses disinhibits spinal PKCγ interneurons and drives pain hypersensitivity in mice. This demonstrates that loss of glycinergic inhibitory control in the spinal cord is a causal mechanism in chronic pain. The finding positions glycinergic synapses as therapeutic targets for pain management.

Neuroligins and neurexins regulate synapse balance, and their dysfunction has been associated with neuropsychiatric disorders. Because glycinergic synapses are part of the inhibitory synapse landscape, altered adhesion molecule function can shift inhibitory tone and contribute to disease phenotypes. This links GO:0098690 to broader questions in neurodevelopmental and psychiatric research.

Glycinergic synapses are essential for early zebrafish motility and motor rhythm generation, indicating a conserved role in locomotor development. Impairments in glycinergic synapse formation or maturation can therefore affect motor circuit development [2,8]. KCC2-dependent chloride regulation is particularly important for the maturation of these synapses in spinal cord neurons.

Patch-clamp recordings measure glycinergic synaptic currents and reveal how receptor number, release-site organization and transporter activity shape current kinetics. These experiments provide functional readouts of glycinergic synapse strength and are often combined with genetic perturbations [5,8].

Fluorescence imaging of glycine receptors, gephyrin and presynaptic markers allows quantification of glycinergic synapse density and colocalization. Tagged knock-in models enable live imaging of receptor clustering and synapse assembly. High-resolution microscopy can resolve nanoscale organization of release sites and receptor clusters.

RNA-seq and single-cell transcriptomics identify genes enriched in glycinergic neurons and synapses, supporting functional annotation to GO:0098690 [1,7]. Proteomic analysis of inhibitory postsynaptic densities can reveal gephyrin-associated complexes and receptor subunits. These datasets help prioritize candidate genes for CRISPR validation.

Pooled CRISPR screens can identify genes that regulate glycinergic synapse formation, maintenance or pruning in neurons and glia. Such screens are particularly useful for discovering pathways involved in microglial pruning of glycinergic synapses. Hits can then be validated with targeted knockout or knock-in models [3,8].

Researchers studying glycinergic synapse-related genes often need to determine whether a candidate gene is causally involved in synapse formation, function or pathology. EDITGENE provides end-to-end CRISPR services that enable precise genetic manipulation of glycinergic synapse components in relevant cell and neuronal models.

GO:0098690 (glycinergic synapse) is a well-defined cellular component that captures the structure and function of fast inhibitory synapses using glycine as a neurotransmitter. Its core components, including glycine receptors, gephyrin, GLYT2 and KCC2, are essential for inhibitory control in spinal, brainstem and retinal circuits [4,7,8]. Dysfunction of these synapses contributes to hyperekplexia, chronic pain and neuropsychiatric conditions, making the term highly relevant for translational research [3,4,6]. Modern CRISPR-based models and multi-omics methods provide powerful tools to dissect glycinergic synapse biology and to validate candidate genes identified in screens [3,5,8]. EDITGENE supports this research with knockout, point-mutation, knock-in, overexpression and library screening services tailored to glycinergic synapse studies.